CNR2
Cannabinoid receptor 2
As of the edition of 20 October 2026, CNR2 (cannabinoid receptor 2, UniProt P34972) has 10 drugs tested at it and 11 companies on the list, 8 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P34972
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- In more than one place
- Solved structures
- 14
- Disease areas
- Nervous system; Skin and connective tissue; Bones, joints and muscles; Digestive system; Immune system; Inherited and neonatal; Eye; Heart and blood vessels
- Registered trials of its drugs
- 27
Drugs at this target
| Status | Count |
|---|---|
| Active | 2 |
| Went quiet | 4 |
| Stopped | 3 |
| Status not established | 1 |
| Total | 10 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Lenabasum | Went quiet | Phase 3 | none listed |
| GW842166X | Stopped | Phase 2 | none listed |
| Etrinabdione | Active | Phase 2 | none listed |
| Olorinab | Stopped | Phase 2 | none listed |
| NTRX-07 | Active | Phase 2 | none listed |
| S-777469 | Went quiet | Phase 2 | none listed |
| LY2828360 | Went quiet | Phase 2 | none listed |
| SAD448 | Went quiet | Phase 1 | none listed |
| TT-816 | Stopped | Phase 2 | none listed |
| Vicasinabin | Status not established | Phase 2 | none listed |
10 of 10 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 8 |
| Engaged | 2 |
| Undetermined | 1 |
| Total on the list | 11 |
The other 8 companies at CNR2
In the product11 companies in all; 8 are not named here, and no score is.
See the 11 companies at CNR2, ranked, with the facts behind eachRequest access. Nothing is shown until you do.